Literature DB >> 20217530

Pulmonary drug delivery: medicines for inhalation.

Andreas Henning1, Stephanie Hein, Marc Schneider, Michael Bur, Claus-Michael Lehr.   

Abstract

Mankind has inhaled substances for medical and other reasons for thousands of years, notably resulting in the cultural manifestations of tobacco and opium smoking. Over the course of time concepts of pulmonary application, including inhalation devices and drug formulations, have been and still are being continuously developed. State of the art instruments even allow for individualized drug application by adaptation of the inhalation procedure to the breathing pattern of the patient. Pulmonary drug delivery offers promising advantages in comparison to "classical" drug administration via the oral or transcutaneous routes, which is also reflected by an increasing interest and number of marketed products for inhalation therapy. However, the lungs' efficient clearance mechanisms still limit the benefit of many therapeutic concepts. In consequence the objective of current research and development in pulmonary drug delivery is to overcome and to control drug clearance from the intended target site. Here, several of the most auspicious future drug delivery concepts are presented and discussed in order to give the reader an insight into this emerging field of medicine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20217530     DOI: 10.1007/978-3-642-00477-3_6

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  5 in total

1.  Dissolution techniques for in vitro testing of dry powders for inhalation.

Authors:  Sabine May; Birte Jensen; Markus Wolkenhauer; Marc Schneider; Claus Michael Lehr
Journal:  Pharm Res       Date:  2012-04-20       Impact factor: 4.200

Review 2.  Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.

Authors:  Anil Kumar; Fei Chen; Anbu Mozhi; Xu Zhang; Yuanyuan Zhao; Xiangdong Xue; Yanli Hao; Xiaoning Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanoscale       Date:  2013-09-21       Impact factor: 7.790

Review 3.  Gene Therapy for Acute Respiratory Distress Syndrome.

Authors:  Jing Liu; David A Dean
Journal:  Front Physiol       Date:  2022-01-17       Impact factor: 4.566

Review 4.  Genetic Delivery and Gene Therapy in Pulmonary Hypertension.

Authors:  Nabham Rai; Mazen Shihan; Werner Seeger; Ralph T Schermuly; Tatyana Novoyatleva
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

5.  In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383.

Authors:  Ayşe Ufuk; Graham Somers; J Brian Houston; Aleksandra Galetin
Journal:  Pharm Res       Date:  2015-07-30       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.